October 20th, 20210WASHINGTON D.C. — The White House has rolled out detailed plans for the expected authorization of the Pfizer COVID-19 vaccine for children.
Federal regulators will meet over the next two weeks to weigh the benefits of giving shots to children aged 5 to 11.
Within hours of the formal approval, which is expected after the Centers...